LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.1
12.88 84.90 10 531 0.0188 -0.5546
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
12.88 84.90 1075 531 2.0245 1.6112
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
14.58 84.90 153 663 0.2306 0.2197
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
14.58 84.90 952 663 1.4350 1.2590
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
14.58 84.90 178 663 0.2683 0.2835
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
14.58 84.90 1171 663 1.7651 1.4223
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
14.58 84.90 16 663 0.0241 -0.4303
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
14.58 84.90 1133 663 1.7079 1.3955
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
16.29 84.90 303 766 0.3951 0.4929
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
16.29 84.90 939 766 1.2245 1.1317
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
16.29 84.90 425 766 0.5542 0.6607
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
16.29 84.90 1160 766 1.5127 1.2784
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
16.29 84.90 23 766 0.0300 -0.3372
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
16.29 84.90 1255 766 1.6365 1.3356
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
17.99 84.90 379 898 0.4216 0.5519
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
17.99 84.90 881 898 0.9800 0.9882
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
17.99 84.90 505 898 0.5618 0.6884
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
17.99 84.90 1092 898 1.2147 1.1176
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
17.99 84.90 26 898 0.0289 -0.2936
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
17.99 84.90 1143 898 1.2714 1.1462
MN20160318_Q02
N17
MCF 10A-H2B-mCherry Neratinib
0.1
19.69 84.90 775 1239 0.6253 0.7714
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
19.69 84.90 918 1239 0.7407 0.8506
MN20160318_Q02
C10
MCF 10A-H2B-mCherry Neratinib
0.1
19.69 84.90 751 1239 0.6059 0.7570
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
19.69 84.90 939 1239 0.7576 0.8615
MN20160318_Q02
J05
MCF 10A-H2B-mCherry Neratinib
0.1
19.69 84.90 38 1239 0.0307 -0.1877
MN20160318_Q02
N17